This study provides one of the largest real-world descriptions to date of how adults with overweight or obesity use and switch GLP-1RAs over time, said first author Luyu (Amber) Xie, Ph.D., Pharm.D., Assistant Professor in the Peter ODonnell Jr
10.1111/jcpt.13076 70 HillZ.McCartyP
Zembron-Lacny, A., Szyszka, K., and Szygula, Z
The lack of reliable biomarkers makes diagnosis, as well as developing more efficacious treatments, difficult (Pinna, 2019)
From what I reviewed, it offers full-dose compounded semaglutide and tirzepatide instead
As of January 2026, more than 70,000 patients were already being treated with Mounjaro in France without reimbursement, illustrating the scale of suppressed demand now set to be released